The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
A polymer library approach to suicide gene therapy for cancer
Open accessAbstract
Optimal gene therapy for cancer must ( i ) deliver DNA to tumor cells with high efficiency, ( ii ) induce minimal toxicity, and ( iii ) avoid gene expression in healthy tissues. To this end, we generated a library of >500 degradable, poly(β-amino esters) for potential use as nonviral DNA vectors. Using high-throughput methods, we screened this library in vitro for transfection efficiency and cytotoxicity. We tested the best performing polymer, C32, in mice for toxicity and DNA delivery after intratumor and i.m. injection. C32 delivered DNA intratumorally ≈4-fold better than one of the best commercially available reagents, jetPEI (polyethyleneimine), and 26-fold better than naked DNA. Conversely, the highest transfection levels after i.m. administration were achieved with naked DNA, followed by polyethyleneimine; transfection was rarely observed with C32. Additionally, polyethyleneimine induced significant local toxicity after i.m. injection, whereas C32 demonstrated no toxicity. Finally, we used C32 to deliver a DNA construct encoding the A chain of diphtheria toxin (DT-A) to xenografts derived from LNCaP human prostate cancer cells. This construct regulates toxin expression both at the transcriptional level by the use of a chimeric-modified enhancer/promoter sequence of the human prostate-specific antigen gene and by DNA recombination mediated by Flp recombinase. C32 delivery of the A chain of diphtheria toxin DNA to LNCaP xenografts suppressed tumor growth and even caused 40% of tumors to regress in size. Because C32 transfects tumors locally at high levels, transfects healthy muscle poorly, and displays no toxicity, it may provide a vehicle for the local treatment of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Synthetic DNA delivery systems
Luo, D., & Saltzman, W. M. (2000) · Nature Biotechnology · doi:10.1038/71889 · Cited by 1,626
Prostate cancer in a transgenic mouse.
Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., & Rosen, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3439 · Cited by 1,294
One molecule of diphtheria toxin fragment a introduced into a cell can kill the cell
Yamaizumi, M., Mekada, E., Uchida, T., & Okada, Y. (1978) · Cell · doi:10.1016/0092-8674(78)90099-5 · Cited by 745
Diphtheria toxin: mode of action and structure
Collier, R. J. (1975) · Bacteriological Reviews · doi:10.1128/br.39.1.54-85.1975 · Cited by 671
Anderson, D. G., Lynn, D. M., & Langer, R. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200351244 · Cited by 504
Self-citationNonviral Gene Therapy: The Promise of Genes as Pharmaceutical Products
Ledley, F. D. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.9-1129 · Cited by 468
Nucleotide sequence of the structural gene for diphtheria toxin carried by corynebacteriophage beta.
Greenfield, L., Bjorn, M. J., Horn, G., Fong, D., Buck, G. A., Collier, R. J., & Kaplan, D. A. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.22.6853 · Cited by 308
Synthesis of Poly(β-amino ester)s Optimized for Highly Effective Gene Delivery
Akinc, A., Anderson, D. G., Lynn, D. M., & Langer, R. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034067y · Cited by 285
Self-citationMaxwell, I. H., Maxwell, F., & Glode, L. M. (1986) · PubMed · Cited by 127
Wang, J., Zhang, P.-C., Mao, H.-Q., & Leong, K. W. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301794 · Cited by 117
Cited by
Thermo- and pH-responsive polymers in drug delivery☆
SCHMALJOHANN, D. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.020 · Cited by 3,023
Design and development of polymers for gene delivery
Pack, D. W., Hoffman, A. S., Pun, S., & Stayton, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1775 · Cited by 2,568
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications
Shi, J., Votruba, A. R., Farokhzad, O. C., & Langer, R. (2010) · Nano Letters · doi:10.1021/nl102184c · Cited by 1,612
Self-citationBiodegradable synthetic polymers: Preparation, functionalization and biomedical application
Tian, H., Tang, Z., Zhuang, X., Chen, X., & Jing, X. (2012) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.06.004 · Cited by 1,293
DNA vaccines: ready for prime time?
Kutzler, M. A., & Weiner, D. B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2432 · Cited by 1,077
Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia
Liu, J.-N., Bu, W., & Shi, J. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00525 · Cited by 838
Nanomedicine: Developing smarter therapeutic and diagnostic modalities☆
FAROKHZAD, O., & LANGER, R. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.011 · Cited by 800
Self-citationNucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)
Lächelt, U., & Wagner, E. (2015) · Chemical Reviews · doi:10.1021/cr5006793 · Cited by 600
A combinatorial polymer library approach yields insight into nonviral gene delivery
Green, J. J., Langer, R., & Anderson, D. G. (2008) · Accounts of Chemical Research · doi:10.1021/ar7002336 · Cited by 579
Self-citationPolymers for gene delivery across length scales
Putnam, D. (2006) · Nature Materials · doi:10.1038/nmat1645 · Cited by 572
Targeted nanoparticles for cancer therapy
Gu, F. X., Karnik, R., Wang, A. Z., Alexis, F., Levy-Nissenbaum, E., Hong, S., Langer, R. S., & Farokhzad, O. C. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70083-x · Cited by 478
Self-citationWang, M., Liu, H., Li, L., & Cheng, Y. (2014) · Nature Communications · doi:10.1038/ncomms4053 · Cited by 415
Chertok, B., David, A. E., & Yang, V. C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.043 · Cited by 369
Thomas, M., Lu, J. J., Ge, Q., Zhang, C., Chen, J., & Klibanov, A. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502067102 · Cited by 366
JEWELL, C., & LYNN, D. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.02.010 · Cited by 297
Gold, Poly(β-amino ester) Nanoparticles for Small Interfering RNA Delivery
Lee, J.-S., Green, J. J., Love, K. T., Sunshine, J., Langer, R., & Anderson, D. G. (2009) · Nano Letters · doi:10.1021/nl9009793 · Cited by 276
Self-citationDeans, T. L., Cantor, C. R., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.05.045 · Cited by 275
Magnetic targeting for site-specific drug delivery: applications and clinical potential
Polyak, B., & Friedman, G. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240802662795 · Cited by 260
Nanoparticle–aptamer bioconjugates for cancer targeting
Farokhzad, O. C., Karp, J. M., & Langer, R. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.3.311 · Cited by 256
Self-citationBiodegradable, polymeric nanoparticle delivery systems for cancer therapy
Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2007) · Nanomedicine · doi:10.2217/17435889.2.5.669 · Cited by 249
“Cationic polymers in particular have demonstrated the ability to form nanoparticle complexes with DNA [45–47] and siRNA [48–50] for cancer treatment (Figure 2B).”
BackgroundSelf-citationThe landscape of nanoparticle-based siRNA delivery and therapeutic development
Moazzam, M., Zhang, M., Hussain, A., Yu, X., Huang, J., & Huang, Y. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.01.005 · Cited by 230
Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems
Rezaee, M., Oskuee, R. K., Nassirli, H., & Malaekeh-Nikouei, B. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.023 · Cited by 200
Metadata
- Authors
- Anderson, D. G., Peng, W., Akinc, A., Hossain, N., Kohn, A., Padera, R., Langer, R., & Sawicki, J. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-11
- Volume
- 101
- Issue
- 45
- Pages
- 16028-16033
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2051778480
- Cited by
- 258
- References
- 12
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.